| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 1,099,900 | 1,279,500 | 1,312,400 | 1,340,000 | | Cost of Revenue | 876,900 | 1,041,800 | 1,020,400 | 1,036,200 | | | Gross Profit | 223,000 | 237,700 | 292,000 | 303,800 | | | Operating Expenses | | Research Development | 27,400 | 30,400 | 35,700 | 30,200 | | Selling General and Administrative | 173,600 | 255,100 | 218,400 | 251,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 22,000 | (47,800) | 37,900 | 22,600 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (6,700) | (8,700) | (6,100) | (11,800) | | Earnings Before Interest And Taxes | 15,300 | (56,500) | 31,800 | 10,800 | | Interest Expense | 21,800 | 20,800 | 21,500 | 21,200 | | Income Before Tax | (6,500) | (77,300) | 10,300 | (10,400) | | Income Tax Expense | 15,600 | (19,300) | 45,000 | 3,600 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (22,100) | (58,000) | (34,700) | (14,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (22,100) | (58,000) | (34,700) | (14,000) | | Preferred Stock And Other Adjustments | (2,300) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($24,400) | ($58,000) | ($34,700) | ($14,000) |
|
0.45% Nasdaq 
0.20%
Income Statement
